[ad_1] Moderna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for…
Science/Technology
-
-
STOCK MARKET
Plastic waste is such a big issue, Estée Lauder is looking to space for help
by userby user[ad_1] It may sound like an unusual alliance: an Earth-orbiting space lab and a major…
-
STOCK MARKET
House to vote Thursday on chips and science bill, but measure faces some trouble after Manchin bombshell
by userby user[ad_1] The U.S. House of Representatives is slated to vote Thursday on a $280 billion…
-
STOCK MARKET
There’s real value for auto makers in the metaverse. Those who say it’s just a play world are wrong.
by userby user[ad_1] In October 2021, Facebook announced it would change its name to Meta META, -7.59%.…
-
STOCK MARKET
Here’s a harsh reality check on using trees and carbon capture to fight climate change
by userby user[ad_1] When politicians talk about reaching “net zero” emissions, they’re often counting on trees or technology that…
-
STOCK MARKET
‘Several hundred thousand’ new COVID cases a day aren’t being reported as hospitalizations keep climbing
by userby user[ad_1] While fears may be growing that another COVID-19 surge will be upon us in…
-
[ad_1] There’s a certain kind of persnickety person who is hyper aware of foodborne illness.…
-
STOCK MARKET
Tour de France winner will burn the equivalent of 210 Big Macs in 24 days
by userby user[ad_1] Imagine you begin pedaling from the start of Stage 12 of this year’s Tour de France. Your…
-
STOCK MARKET
Black patients were rarely included in clinical trials — until the COVID-19 vaccines. Will these changes stick?
by userby user[ad_1] Stephanie Walker, a Black retired nurse who was diagnosed with metastatic breast cancer in…
-
STOCK MARKET
Novavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
by userby user[ad_1] Novavax’s NVAX, +0.61% COVID-19 vaccine candidate played a front-and-center role during this week’s debate…